Lighthouse Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Lighthouse Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Buy	+97,000	New	+$3.23M	0.09%	280
2025 Q4	–	Sell	-45,000	Closed	-$909K	–	1047
2025 Q3	$909K	Sell	45,000 -16,000	-26%	-$281K	0.03%	455
2025 Q2	$1.02M	Buy	+61,000	New	+$984K	0.04%	382
2025 Q1	–	Sell	-80,000	Closed	-$1.76M	–	639
2024 Q4	$1.76M	Sell	80,000 -19,971	-20%	-$363K	0.06%	303
2024 Q3	$1.8M	Sell	99,971 -320,029	-76%	-$5.6M	0.07%	278
2024 Q2	$6.83M	Buy	+420,000	New	+$6.47M	0.27%	103

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Lighthouse Investment Partners's TEVA Position: Q2 2026 in Review

Lighthouse Investment Partners opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 97,000 shares worth $3.29M. The stake represents 0.09% of the portfolio and ranks #280 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in TEVA as recently as Q3 2025.

Lighthouse Investment Partners first reported a position in TEVA in Q2 2024 and has held it in 6 quarters since. The position peaked at $6.83M in Q2 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Lighthouse Investment Partners held 97,000 shares of Teva Pharmaceuticals worth $3.29M as of Q2 2026.
Teva Pharmaceuticals was a new Lighthouse Investment Partners position in Q2 2026.
Teva Pharmaceuticals made up 0.09% of Lighthouse Investment Partners's portfolio in Q2 2026, its #280 holding.
Lighthouse Investment Partners first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
Lighthouse Investment Partners's Teva Pharmaceuticals position peaked at $6.83M in Q2 2024.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.